RxDoctor Payments Data

Heather Rafal

Foot & Ankle Surgery · Wilmington, DENPI 1023346335

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,054 of the $3,608 with a category attached, or 84.7%. It is spread thinly across 37 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.

$3,608in general payments, 2019–2025

Across 106 payments — averaging $34.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$615
  • Liberty Surgical Inc.$476
  • Stryker$391
  • Sandoz$235
  • Bioventus LLC$156
  • Medtronic$139
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$3,05485%
  • Education$55315%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,608 in reported general payments places this provider in the 55th percentile of 32 foot & ankle surgery providers in Delaware.

See all foot & ankle surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$201,539
Medicare patients
604
Services billed
3,565

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole20$714
Cephalexin23$619
Econazole Nitrate22$503
Mupirocin49$390
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$274
Clindamycin Hcl16$192
Methylprednisolone18$123
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$78
Meloxicam21$65
Prednisone20$59

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →